Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook By: Benzinga via Benzinga December 19, 2015 at 17:08 PM EST Vamil Divan of Credit Suisse offered his 2016 outlook for large-cap U.S. pharmaceuticals. Divan noted that sector-wide ... Read More >> Related Stocks: Bristol-Myers Squibb Eli Lilly Johnson & Johnson Merck & Co Pfizer